The application describes a process for the preparation of microcapsules, wherein the microcapsules have a volume average diameter d of 15 to 90 μηη and a percentage of the shell weight of 3 to 40%, with reference to the total weight of capsules, wherein the shell of the microcapsules comprises at least one polyurea and the core comprises at least one lipophilic component, comprising the step of adding hydroxyalkylcellulose to a dispersion of polyurea microcapsules, microcapsules and their uses.

Disclosed is a capsule including: an internal phase including at least one plant cell; and an external gel phase, that totally encapsulates the internal phase at its periphery, the external phase including at least one surfactant and at least one polyelectrolyte in the gel state.

Disclosed is a capsule including: an internal phase including at least one plant cell; and an external gel phase, that totally encapsulates the internal phase at its periphery, the external phase including at least one surfactant and at least one polyelectrolyte in the gel state.

The present invention provides a method of producing hollow particles for reducing light scattering in an antireflection coating. This method includes synthesizing core-shell particles including a core containing an organic compound as a major component and a shell containing an inorganic-based compound as a major component in an aqueous medium, dispersing the core-shell particles in an organic solvent, and preparing hollow particles by heating the core-shell particles dispersed in the organic solvent to remove the core therefrom.

The present invention provides a method of producing hollow particles for reducing light scattering in an antireflection coating. This method includes synthesizing core-shell particles including a core containing an organic compound as a major component and a shell containing an inorganic-based compound as a major component in an aqueous medium, dispersing the core-shell particles in an organic solvent, and preparing hollow particles by heating the core-shell particles dispersed in the organic solvent to remove the core therefrom.

Present disclosure provides a method of forming a liquid-encapsulated core material, encapsulated core material compositions, and uses thereof, where the encapsulated core material is formed by providing an interfacial fluid layered on a host fluid, and passing a core material through the interfacial fluid and into the host fluid such that the interfacial fluid forms a shell around the core material. By so encapsulating the core material, it is protected from the host fluid.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

Provided herein is a nanopore structure, which in one aspect is a “carbon nanotube porin”, that comprises a short nanotube with an associated lipid coating. Also disclosed are compositions and methods enabling the preparation of such nanotube/lipid complexes. Further disclosed is a method for therapeutics delivery that involves a drug delivery agent comprising a liposome with a NT loaded with a therapeutic agent, introducing the therapeutic agent into a cell or a tissue or an organism; and subsequent release of the therapeutic agents into a cell.

A polymeric material can be deposited or coated on a surface of a hollow microsphere to produce a sacrificial microsphere. Sacrificial microspheres can provide a cost-effective way to produce lightweight plastics and composites.

Comestible products, for example beverage products, are disclosed containing encapsulated probiotic bacteria having resistance to subjection to at least thermal and acidic conditions. Beverage products include at least one aqueous liquid and capsules comprising a gelled mixture of alginate and denatured protein, and probiotic bacteria entrapped within the gelled mixture. The average particle size of the capsules is optionally less than 1000 microns (μm) in diameter, such as less than 500 μm in diameter. Methods are provided for making such encapsulated probiotics by providing a mixture comprising sodium alginate, denatured protein and active probiotic cells, and combining the mixture with a divalent cation to initiate cold gelation of the sodium alginate and denatured protein to form a second mixture. The second mixture is passed through an opening having a diameter of less than 1000 μm to form capsules. The weight ratio of protein to alginate is from 1:1 to 9:1.